Company intelligence

AUTL

Autolus Therapeutics plc · NASDAQ · Healthcare

Price$1.90-2.32% · −$0.05

Market cap504.34MEquity value

P / E-1.7Trailing ratio

Volume196.36KLatest session

Market data

AUTL price chart

TradingView

Related signals

1 min delayed

Browse public AUTL signals with their source context and measured market impact. Open any signal for its permanent analysis page.

AUTLNov 25, 2025-3.18% since signal

Why Is Autolus Therapeutics Stock Trading Higher On Tuesday?

NICE recommends Aucatzyl for NHS use in r/r B-ALL patients. Aucatzyl will have routine NHS commissioning availability. Autolus plans an imminent launch in England and Wales. Conditional marketing authorization from MHRA was granted in April 2025. AUTL stock rose 10.48% to $1.37 at publication.

View signal analysis

Research